CA2176145C - Implants oculaires biocompatibles - Google Patents

Implants oculaires biocompatibles Download PDF

Info

Publication number
CA2176145C
CA2176145C CA002176145A CA2176145A CA2176145C CA 2176145 C CA2176145 C CA 2176145C CA 002176145 A CA002176145 A CA 002176145A CA 2176145 A CA2176145 A CA 2176145A CA 2176145 C CA2176145 C CA 2176145C
Authority
CA
Canada
Prior art keywords
implant
agent
use according
drug
migration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002176145A
Other languages
English (en)
Other versions
CA2176145A1 (fr
Inventor
Vernon G. Wong
Frank Kochinke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/153,184 external-priority patent/US5443505A/en
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of CA2176145A1 publication Critical patent/CA2176145A1/fr
Application granted granted Critical
Publication of CA2176145C publication Critical patent/CA2176145C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Prostheses (AREA)
  • Medicinal Preparation (AREA)

Abstract

Selon l'invention, on utilise dans un but thérapeutique des implants comprenant des agents actifs que l'on introduit dans un espace suprachoroïdien ou dans une région avasculaire de l'oeil. La libération des médicaments dans l'oeil est régulée et maintenue pendant de longues périodes de temps, sans qu'il y ait des niveaux importants de répartition des médicaments en dehors du site d'administration.
CA002176145A 1993-11-15 1994-11-09 Implants oculaires biocompatibles Expired - Lifetime CA2176145C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/153,184 US5443505A (en) 1993-11-15 1993-11-15 Biocompatible ocular implants
US08/153,184 1993-11-15
PCT/US1994/012898 WO1995013765A1 (fr) 1993-11-15 1994-11-09 Implants oculaires biocompatibles

Publications (2)

Publication Number Publication Date
CA2176145A1 CA2176145A1 (fr) 1995-05-26
CA2176145C true CA2176145C (fr) 2007-04-10

Family

ID=38007156

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002176145A Expired - Lifetime CA2176145C (fr) 1993-11-15 1994-11-09 Implants oculaires biocompatibles

Country Status (1)

Country Link
CA (1) CA2176145C (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3087238A1 (fr) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Dispositif implantable pour la liberation prolongee d'un compose medicamenteux macromoleculaire
EP3803866A4 (fr) 2018-05-24 2022-03-16 Nureva Inc. Procédé, appareil et supports lisibles par ordinateur pour gérer des sources sonores semi-constantes (persistantes) dans des zones de capture/foyer de microphones
CN111989068B (zh) 2018-05-24 2024-10-25 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
EP4329734A4 (fr) 2021-04-26 2025-04-02 Celanese EVA Performance Polymers LLC Dispositif implantable pour la libération prolongée d'un composé médicamenteux macromoléculaire

Also Published As

Publication number Publication date
CA2176145A1 (fr) 1995-05-26

Similar Documents

Publication Publication Date Title
EP0729324B1 (fr) Implants oculaires biocompatibles
US5164188A (en) Biodegradable ocular implants
US4853224A (en) Biodegradable ocular implants
US4997652A (en) Biodegradable ocular implants
EP0251680B1 (fr) Système bioérodable pour la libération contrôlée d'un médicament
US6331313B1 (en) Controlled-release biocompatible ocular drug delivery implant devices and methods
US6369116B1 (en) Composition and method for treating glaucoma
US20050244465A1 (en) Drug delivery systems and methods for treatment of an eye
US20050244461A1 (en) Controlled release drug delivery systems and methods for treatment of an eye
US20080124377A1 (en) Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
JP2007535552A (ja) α−２アドレナリン受容体アゴニストの眼内インプラントおよび視力の向上方法
WO2006039271A1 (fr) Procede de preparation d'un implant oculaire contenant un poly(alcool de vinyle)
Deshpande et al. Bioerodible polymers for ocular drug delivery
AU731486B2 (en) Biocompatible ocular implants
Law et al. Ocular pharmacology
MXPA97009218A (en) Improved formulation to control the release of drugs by the combination of hydrophilic and hydrophobic agents

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20141110